Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 2/10/2026

Promethazine Use in Pregnancy and Safety Considerations

Guideline Recommendations for Antiemetic Use in Pregnancy

  • The obstetric guideline recommends promethazine as a first‑line anti‑emetic for nausea and vomiting in pregnancy, using a dose of 12.5–25 mg administered every 4–8 hours via oral, intramuscular, or intravenous routes; this aligns with FDA dosing recommendations. 1, 2

Contraindications and Precautions

  • Promethazine should be avoided in patients with narrow‑angle glaucoma, prostatic hypertrophy, or bladder‑neck obstruction because of its anticholinergic effects. 3

REFERENCES

3

Promethazine: Pharmacology, Clinical Role in Endoscopy, and Safety Profile [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026